Trials / Completed
CompletedNCT00823927
Alveolar Macrophage Proteomics in HIV-associated Emphysema
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 365 (actual)
- Sponsor
- Philip Diaz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to examine lung function changes in individuals with HIV infection and to understand why individuals with HIV have increased risk of lung damage from cigarette smoking.
Detailed description
To delineate the natural history of HIV associated emphysema in the HAART era. To compare the alveolar macrophage proteomes from HIV-seropositive smokers with emphysema to the alveolar macrophages proteomes of both HIV+ smokers without emphysema and HIV- smokers. To establish whether coinfection with HIV and Hepatitis C results in accelerated lung disease manifested by decrements in forced expiratory volume and carbon monoxide diffusing capacity.
Conditions
Timeline
- Start date
- 2006-04-21
- Primary completion
- 2008-06-23
- Completion
- 2008-06-23
- First posted
- 2009-01-16
- Last updated
- 2021-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00823927. Inclusion in this directory is not an endorsement.